Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors

Clinical trial NCT05473624 · RECRUITING

Trial details

NCT number: NCT05473624
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-08-23
Primary completion: 2026-12-31
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.